Clinical trial
Evaluation of a Point of Care Analyzer for Lactate Dehydrogenase, HildaNeo, as Support for Decisions When Admitting Newborn to the Neonatal Wards at NPH
NCT02379936 is registered in ClinicalTrials.gov with National Children's Hospital, Vietnam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Point of Care Analyzer for Lactate Dehydrogenase, HildaNeo, as Support for Decisions When Admitting Newborn to the Neonatal Wards at NPH
- Lead sponsor
- National Children's Hospital, Vietnam
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- August 31, 2014
- Enrollment
- 122 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asphyxia, neonatal